Our findings are consistent with studies demonstrating transferrin receptor expression in U87MG12 and GL26113 cells, suggesting that transferrin would be suitable as a ligand for our NPs for assessing receptor-mediated transcytosis and tumor targeting as previously reported in the literature14, 15. Here, TFRC is linked to neoplasm.